News

This preliminary trial was conducted at the National Eye Institute (NEI), which is part of the US National Institute of Health (NIH). The trial, which examined the effect

Approval by the Korean regulatory agency was based on the Australian approval and was completed efficiently in just six months. The approval process is expected to conclude in

The initial product to be jointly promoted in the US is Teva’s ProAirHFA (albuterol sulfate) inhalation aerosol. Additionally, the agreement will provide UCB future joint promotion opportunities with

The lawsuits allege that CryoCath’s products infringe several patents related to CryoCor’s Cardiac Cryoablation System. CryoCor is an exclusive licensee of the patents, and is seeking monetary damages

Kentera was approved through the centralized procedure by the EMEA in 2004 and has been on the market in a number of countries with current sales of over

According to the company, the Arachnova patent rights, which include granted patents and pending applications related to the use of DDP225 for the treatment of functional bowel disorders,

Pro-Stat has been shown to be an effective nutritional intervention to aid in the treatment of pressure ulcers, protein energy malnutrition, recent weight loss, hypoalbuminemia, and end stage

The trial was designed to assess the effects of PRX-03140 following two weeks of treatment as monotherapy and separately in combination with donepezil in patients with mild Alzheimer’s

The filing for Keppra is supported by a Phase III, multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of extended-release levetiracetam tablets (2x500mg) once-daily as